Type
Internal restructuring
Country
World
Region
Location of affected unit(s)
Minnesota (USA), Copenhagen, and others
Sector
Professional Services
Scientific, Architectural And Engineering Technical Activities
Scientific Research And Development
72 - Scientific research and development

300 jobs
Number of planned job losses
Job loss
Announcement Date
5 November 2009
Employment effect (start)
1 December 2009
Foreseen end date

Description

Danish biotech company Genmab, based in Copenhagen, announced 300 dismissals worldwide, mostly in research and manufacturing. The move is part of a broader restructuring effort to cut €130 million in annual costs, as the company shifts more development work to outside contractors. Job losses will occur in Minnesota, USA (between 130 and 170) and Copenhagen (120).


Sources

Citation

Eurofound (2009), Genmab, Internal restructuring in World, factsheet number 69803, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/69803.